Clinical outcome and long‑term prognosis after endoscopic submucosal dissection for colorectal tumors in patients aged 75 years or older: a retrospective observational study.

IF 2.5 3区 医学 Q2 GASTROENTEROLOGY & HEPATOLOGY
Naoki Asayama, Shinji Nagata, Kenjiro Shigita, Yoshihiro Mouri, Shintaro Ooie, Kenta Matsumoto, Taiki Aoyama, Akira Fukumoto, Mayumi Kaneko
{"title":"Clinical outcome and long‑term prognosis after endoscopic submucosal dissection for colorectal tumors in patients aged 75 years or older: a retrospective observational study.","authors":"Naoki Asayama, Shinji Nagata, Kenjiro Shigita, Yoshihiro Mouri, Shintaro Ooie, Kenta Matsumoto, Taiki Aoyama, Akira Fukumoto, Mayumi Kaneko","doi":"10.1007/s00384-024-04765-x","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose: </strong>To determine the clinical outcomes of endoscopic submucosal dissection (ESD) for colorectal tumors in older patients and predictors of mortality.</p><p><strong>Methods: </strong>We retrospectively evaluated 207 lesions in 195 consecutive older patients aged ≥ 75 years who underwent ESD for colorectal tumors between January 2007 and December 2018. Outcomes of ESD were evaluated, and the prognosis was assessed in terms of both curability and the patient's baseline physical condition as determined by several indices. Cox regression analyses were performed to identify factors associated with reduced overall survival (OS).</p><p><strong>Results: </strong>Treatment outcomes included a median procedure time of 55 min, en bloc resection rate of 97%, histological en bloc resection rate of 92%, postoperative bleeding rate of 2.4%, and intraoperative perforation rate of 3.4%. Postoperative bleeding and intraoperative perforation could be treated conservatively. Delayed perforation occurred in one patient and required emergency surgery. Three-year OS was 99.4% and 5-year OS was 95.8%. Overall, three patients experienced recurrence (one local, two distant metastasis), and one patient died of primary cancer. Multivariate analysis identified the Charlson Comorbidity Index (CCI) score ≥ 3 as the only independent predictor of reduced OS (hazard ratio 4.26; 95% confidence interval 1.60-11.38; P = 0.004).</p><p><strong>Conclusion: </strong>Our results suggest that colorectal ESD is safe and effective in older patients aged ≥ 75 years. There was a significant independent association of reduced OS with high CCI score, but not with curability by ESD. The CCI score should be considered when determining the indications for ESD in older patients.</p>","PeriodicalId":13789,"journal":{"name":"International Journal of Colorectal Disease","volume":"39 1","pages":"188"},"PeriodicalIF":2.5000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Colorectal Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00384-024-04765-x","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GASTROENTEROLOGY & HEPATOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose: To determine the clinical outcomes of endoscopic submucosal dissection (ESD) for colorectal tumors in older patients and predictors of mortality.

Methods: We retrospectively evaluated 207 lesions in 195 consecutive older patients aged ≥ 75 years who underwent ESD for colorectal tumors between January 2007 and December 2018. Outcomes of ESD were evaluated, and the prognosis was assessed in terms of both curability and the patient's baseline physical condition as determined by several indices. Cox regression analyses were performed to identify factors associated with reduced overall survival (OS).

Results: Treatment outcomes included a median procedure time of 55 min, en bloc resection rate of 97%, histological en bloc resection rate of 92%, postoperative bleeding rate of 2.4%, and intraoperative perforation rate of 3.4%. Postoperative bleeding and intraoperative perforation could be treated conservatively. Delayed perforation occurred in one patient and required emergency surgery. Three-year OS was 99.4% and 5-year OS was 95.8%. Overall, three patients experienced recurrence (one local, two distant metastasis), and one patient died of primary cancer. Multivariate analysis identified the Charlson Comorbidity Index (CCI) score ≥ 3 as the only independent predictor of reduced OS (hazard ratio 4.26; 95% confidence interval 1.60-11.38; P = 0.004).

Conclusion: Our results suggest that colorectal ESD is safe and effective in older patients aged ≥ 75 years. There was a significant independent association of reduced OS with high CCI score, but not with curability by ESD. The CCI score should be considered when determining the indications for ESD in older patients.

一项回顾性观察研究:75 岁或以上患者接受内镜黏膜下剥离术治疗结直肠肿瘤后的临床疗效和长期预后。
目的:确定老年患者接受内镜黏膜下剥离术(ESD)治疗结直肠肿瘤的临床效果以及死亡率的预测因素:我们回顾性评估了 2007 年 1 月至 2018 年 12 月间连续接受结直肠肿瘤 ESD 治疗的 195 名年龄≥ 75 岁的老年患者的 207 个病灶。我们对ESD的结果进行了评估,并从治愈率和患者基线身体状况两个方面评估了预后,基线身体状况由几项指标决定。进行了Cox回归分析,以确定与总生存率(OS)降低相关的因素:治疗结果包括:中位手术时间为 55 分钟,整块切除率为 97%,组织学整块切除率为 92%,术后出血率为 2.4%,术中穿孔率为 3.4%。术后出血和术中穿孔可采取保守治疗。一名患者发生了延迟穿孔,需要进行紧急手术。三年生存率为 99.4%,五年生存率为 95.8%。总体而言,3名患者复发(1名局部复发,2名远处转移),1名患者死于原发性癌症。多变量分析发现,Charlson疾病综合指数(CCI)评分≥3是降低OS的唯一独立预测因子(危险比4.26;95%置信区间1.60-11.38;P = 0.004):我们的研究结果表明,结直肠ESD对年龄≥75岁的老年患者是安全有效的。OS的降低与CCI评分高有明显的独立关联,但与ESD的可治愈性无关。在确定老年患者的ESD适应症时应考虑CCI评分。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.90
自引率
3.60%
发文量
206
审稿时长
3-8 weeks
期刊介绍: The International Journal of Colorectal Disease, Clinical and Molecular Gastroenterology and Surgery aims to publish novel and state-of-the-art papers which deal with the physiology and pathophysiology of diseases involving the entire gastrointestinal tract. In addition to original research articles, the following categories will be included: reviews (usually commissioned but may also be submitted), case reports, letters to the editor, and protocols on clinical studies. The journal offers its readers an interdisciplinary forum for clinical science and molecular research related to gastrointestinal disease.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信